TR202005416A2 - EFFECTIVE SOLUTIONS AGAINST BIOLOGICAL THREATS AND HAZARDS - Google Patents
EFFECTIVE SOLUTIONS AGAINST BIOLOGICAL THREATS AND HAZARDS Download PDFInfo
- Publication number
- TR202005416A2 TR202005416A2 TR2020/05416A TR202005416A TR202005416A2 TR 202005416 A2 TR202005416 A2 TR 202005416A2 TR 2020/05416 A TR2020/05416 A TR 2020/05416A TR 202005416 A TR202005416 A TR 202005416A TR 202005416 A2 TR202005416 A2 TR 202005416A2
- Authority
- TR
- Turkey
- Prior art keywords
- feature
- human health
- water
- affects
- health
- Prior art date
Links
- 238000000034 method Methods 0.000 claims abstract description 38
- 230000036541 health Effects 0.000 claims abstract description 26
- 244000005700 microbiome Species 0.000 claims abstract description 20
- 241000700605 Viruses Species 0.000 claims abstract description 13
- 239000012530 fluid Substances 0.000 claims abstract description 11
- 201000010099 disease Diseases 0.000 claims abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 9
- 238000011282 treatment Methods 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- 239000007788 liquid Substances 0.000 claims description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 15
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 8
- 238000005507 spraying Methods 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 6
- 108091008146 restriction endonucleases Proteins 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 230000002411 adverse Effects 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 4
- 230000003449 preventive effect Effects 0.000 claims description 3
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 235000011399 aloe vera Nutrition 0.000 claims description 2
- 230000002421 anti-septic effect Effects 0.000 claims description 2
- 230000035876 healing Effects 0.000 claims description 2
- 238000005192 partition Methods 0.000 claims description 2
- 241000894007 species Species 0.000 claims description 2
- 244000186892 Aloe vera Species 0.000 claims 1
- 240000000249 Morus alba Species 0.000 claims 1
- 235000008708 Morus alba Nutrition 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000007844 bleaching agent Substances 0.000 claims 1
- 230000009931 harmful effect Effects 0.000 abstract description 7
- 241001465754 Metazoa Species 0.000 abstract description 6
- 230000007613 environmental effect Effects 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 238000003745 diagnosis Methods 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 210000002345 respiratory system Anatomy 0.000 description 8
- 229910052709 silver Inorganic materials 0.000 description 8
- 239000004332 silver Substances 0.000 description 8
- 239000011521 glass Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000004857 Balsam Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- MPOKJOWFCMDRKP-UHFFFAOYSA-N gold;hydrate Chemical compound O.[Au] MPOKJOWFCMDRKP-UHFFFAOYSA-N 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- AYKOTYRPPUMHMT-UHFFFAOYSA-N silver;hydrate Chemical compound O.[Ag] AYKOTYRPPUMHMT-UHFFFAOYSA-N 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 235000007173 Abies balsamea Nutrition 0.000 description 2
- 239000009611 Arque-Ajeeb Substances 0.000 description 2
- 240000004385 Centaurea cyanus Species 0.000 description 2
- 235000005940 Centaurea cyanus Nutrition 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 244000018716 Impatiens biflora Species 0.000 description 2
- 240000007049 Juglans regia Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000001066 destructive effect Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 235000021056 liquid food Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000006199 nebulizer Substances 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 241001515965 unidentified phage Species 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- 241000502561 Acacia irrorata Species 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 208000002109 Argyria Diseases 0.000 description 1
- 241001554566 Argyria Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000002803 fossil fuel Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- -1 gold ions Chemical class 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 235000021485 packed food Nutrition 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035485 pulse pressure Effects 0.000 description 1
- 231100000628 reference dose Toxicity 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/24—Apparatus using programmed or automatic operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4854—Diagnosis based on concepts of traditional oriental medicine
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/80—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for detecting, monitoring or modelling epidemics or pandemics, e.g. flu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2503/00—Evaluating a particular growth phase or type of persons or animals
- A61B2503/12—Healthy persons not otherwise provided for, e.g. subjects of a marketing survey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2503/00—Evaluating a particular growth phase or type of persons or animals
- A61B2503/40—Animals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- General Business, Economics & Management (AREA)
- Animal Behavior & Ethology (AREA)
- Primary Health Care (AREA)
- Business, Economics & Management (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Alternative & Traditional Medicine (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Bu buluş; İnsan, hayvan, bitki hatta faydalı bazı mikroorganizmaların sağlığı ve yaşamsal ve çevresel denge için tehdit oluşturan ve/veya bozan, doğal veya yapay zararlı virüsler dâhil her türlü biyolojik tehdit ve tehlikelere karşı etkin ve etkili bir model ile önlemler alınması, çözümler bulunması ve bu kapsamda ortaya çıkan çıkabilecek olan ve salgın riski taşıyan hastalıkları teşhis, tanı, tedavi eden mayi adı verilen ürün ve takip yöntemleriyle ilgilidir.This invention; Taking measures and finding solutions with an effective and effective model against all kinds of biological threats and dangers, including natural or artificial harmful viruses that threaten and / or disrupt the health of human, animal, plant and even some beneficial microorganisms and vital and environmental balance, and within this scope It is concerned with the diagnosis, diagnosis, treatment of the diseases that may arise and with epidemic risk, and the products called fluids and follow-up methods.
Description
TARIFNAME BIYOLOJIK TEHDIT VE TEHLIKELERE KARSI ETKILI ÇÖZÜMLER Bu bulus; Insan, hayvan, bitki hatta faydali bazi mikroorganizmalarin sagligi ve yasamsal ve çevresel denge için tehdit olusturan ve/veya bozan, dogal veya yapay zararli virüsler dâhil her türlü biyolojik tehdit ve tehlikelere karsi etkin ve etkili bir model ile önlemler alinmasi, çözümler bulunmasi ve bu kapsamda ortaya çikan çikabilecek olan ve salgin riski tasiyan hastaliklari teshis, tani, tedavi eden mayi adi verilen ürün ve takip yöntemleriyle ilgilidir. DESCRIPTION EFFECTIVE SOLUTIONS TO BIOLOGICAL THREATS AND HAZARDS This invention; The health and well-being of humans, animals, plants and even some beneficial microorganisms. natural or artificial, threatening and/or disrupting the vital and environmental balance. effectively and effectively against all kinds of biological threats and dangers, including harmful viruses. taking measures with the model, finding solutions and Fluid for diagnosing, diagnosing and treating diseases that may occur and carry the risk of epidemic It is related to the named product and tracking methods.
A. Bulusun ilgili oldugu teknik saha ve teknigin bilinen durumu: Ilgili oldugu ana teknik sahalar Saglik ve Çevre sektörleri, dolayli olarak Enerji ve Sanayi sektörleri olup, dünya çapinda olusacak Biyolojik tehditlere karsi kademeli bir derinlik olusturacak etkili ve etken bir model ve yöntem henüz yoktur. A. The technical field to which the invention is related and the state of the art: The main technical fields of interest are the Health and Environment sectors, indirectly Energy and They are industrial sectors and will be gradually developed against biological threats that will occur around the world. There is not yet an effective and effective model and method that will create a depth.
Bu teknik sahada, Biyolojik tehditlere karsi bazi dezenfektanlar ve solüsyonlar ile canlilarin yasam alanlarinda seyrek periyotlarla sanitasyon ve gerek görüldügünde hijyen tedbirleri uygulanmaktadir. This technique is used in the field with some disinfectants and solutions against biological threats. Sanitation in rare periods in the living areas of living things and when necessary hygiene measures are applied.
Epidemi hatta pandemi olasiliklari çok yüksek bir salgin görüldügünde olaganüstü tedbirler uygulanmakta ve sanitasyon ile hijyen tedbirleri kademeli olarak yükseltilmektedir. Ancak dünya çapinda bir salginda etkili ve etken olabilecek bir model veya yol-yöntem henüz hiçbir ülkede de yoktur. The probability of an epidemic or even a pandemic is extraordinary when an epidemic is seen. measures are being implemented and sanitation and hygiene measures are gradually being implemented. is being raised. However, it is an effective and causative agent in a worldwide epidemic. model or way-method is not yet available in any country.
Bunun yani sira biyolojik tehdit olustugunda, ilk önce yapisi taninmaya, akabinde yapisi net olarak tespit edildiginde buna uygun metoti tedavi, ilaç veya asi gelistirilip derhal uygulanmaya çalisilmaktadir. Özellikle yapay üretilen veya yapisi bilinmeyen mikroorganizma salginlarinda ki en etkilileri virüsler olup. tam tedbir alip kontrol altina alinincaya kadar uzun bir süre geçtiginden dünya çapinda yikici etkileri yüksek olmaktadir. In addition, when a biological threat occurs, its structure must first be recognized, and then When its structure is clearly determined, the appropriate method, treatment, medication or vaccine are being developed and implemented immediately. Especially in the outbreaks of artificially produced or unknown microorganism, the effective ones are viruses. a long period of time until full precaution is taken and brought under control. Since it has passed, its destructive effects are high worldwide.
Biyolojik tehlikelerin kontrol altina alinmasi, canli organizma içerisinde olusan yikici etkilere karsi varsa asi veya ilaç uygulamasi, yoksa gelistirilmesi metoduna dayanir. Dolayisiyla dâhili ve harici önlemler hastalik belirtisi ile birlikte baslar ancak kesin çözüm uzun zaman gerektirir. Zaman kaybi, dünya çapinda olusan bir felakette inanilmaz maddi, manevi ve can kayiplari dogurmaktadir. Controlling biological hazards, occurring in living organisms If there is a vaccine or drug application against the destructive effects, if not, the method of development should be applied. it lasts. Therefore, internal and external measures begin with the symptom of the disease. but the exact solution takes a long time. Waste of time is a worldwide phenomenon. It causes incredible material, moral and life losses in disasters.
Tüm bunlarin yani sira dünyamiz artik yeni bir döneme girmistir. Ülkeler arasi biyolojik saldirilar, fosil yakitlardan enerji üretimi küresel isinma ve inanilmaz doga ve çevre katliami sonucu olusan iklim degisiklikleri/krizi ve bunun dogal sonucu eriyen kutuplardan yayilabilecek bilinmeyen mikroorganizmalar. Bunlarin en tehlikelileri ise virüslerdir. Havadan, karadan, sudan veya insanlar/hayvanlar araciligi yani Bulas ile veya Bakterileri kullanarak ve yok ederek çogalabildikleri için virüslerin yayilma riskleri çok yüksektir. In addition to all these, our world has now entered a new era. International biological attacks, energy production from fossil fuels, global warming and unbelievable nature and climate changes/crisis as a result of environmental massacre and its natural consequence unknown microorganisms that may spread from melting poles. most of them The dangerous ones are viruses. By air, land, water or people/animals that they can multiply by means of infection or by using and destroying Bacteria. The risk of spreading viruses is very high.
Hatta gelecekte kaçinilmaz olan uzay arastirmalari sonucu baska uzay cisimlerine seyahat dönüsü getirilmesi muhtemel yine bilinmeyen pek çok yüksek isilara bile dayanikli mikroorganizma veya benzeri yapilar bulusun ilgili oldugu teknik saha ve bilinen durumu kisaca özetlemektedir. In fact, in the future, as a result of space exploration, which is inevitable, other space objects Even to many unknown high temperatures that are likely to be brought on the return of travel. durable microorganisms or similar structures, the technical field to which the invention relates, and It briefly summarizes the known situation.
B. Bulusun çözümünü amaçladigi teknik problemler: Biyolojik tehditlere karsi kademeli bir derinlik olusturacak kapsamli bir döngüsel ve dinamik model olusturup, gelistirip, dünya çapinda uygulanabilecek bir yapiya kavusturulmalidir. Bununla birlikte, Biyolojik tehdidin yapisinin tespit edilmesi için geçen zaman kaybini ve dolayisiyla ölümleri engelleyebilecek veya en aza indirecek her türlü mikroorganizmaya karsi genel kullanima sahip ama tam etkili bir organik yani dogal karisim veya bilesimlerle veya baska tekniklerle vakit kaybetmeden soruna aninda müdahale edilerek tehdit acilen yok edilmelidir. B. Technical problems that the invention aims to solve: A comprehensive circular and create a dynamic model, develop it and build a structure that can be applied worldwide. should be cured. However, in order to determine the nature of the biological threat, that can prevent or minimize the loss of time and, therefore, deaths. It has general use but is fully effective against all kinds of microorganisms that will reduce time with an organic, that is, natural mixture or composition, or with other techniques. The threat should be eliminated immediately by intervening immediately without losing the risk.
Kisacasi dünya çapinda geçerli bir döngü model hazirlanmasi ve zaman kaybini en aza indirecek veya yok edecek her türlü zararli mikroorganizmaya etkili bir özel ürün/ürünlerin ve teknik yol ve yöntemlerin ortaya konmasi gereklidir. In short, a worldwide valid loop model preparation and time wasted. A special agent effective against all kinds of harmful microorganisms that will minimize or destroy It is necessary to reveal the product/products and technical ways and methods.
C. Bulusun açiklamasi: Insan sagligi açisindan: Bulus; öncelikle insan sagligini tehdit eden dogal veya yapay zararli virüsler dâhil her türlü zararli mikroorganizmalara karsi, sivi organik madde/maddeler, enzimler ve bunlarin sivi veya buhar (gaz) halindeki bilesik veya karisimlarinin sivi gida gibi verilmesi veya canlilarin solunum yolundan Nebülizatör adi verilen cihazlara takilan nebüllerde bulunan özel sivi bilesik veya karisimlarin, mikro hatta nano boyutlarda solunum yollarindan uygulanmasi, insan vücudu dahilinde ve/veya haricinde etkili ses. isik kaynaklari kullanilmasi veya ULV adi verilen veya benzeri cihazlarla mikro hatta nano partiküller boyutunda çevre temizligi ve dezenfektesi amaciyla kullanilmasi sonucu zararli mikroorganizmalarin yasam döngülerinin kullanilan bu yöntemlerle harici ve dâhili olarak kirilmasi/yok edilmesi yol ve yöntemlerini içerir. C. Description of the invention: In terms of human health: Meet; including natural or artificial harmful viruses that primarily threaten human health. against all kinds of harmful microorganisms, liquid organic matter/substances, enzymes and their liquid or vapor (gas) compounds or mixtures as liquid food or from the respiratory tract of living things to devices called Nebulizers. special liquid compounds or mixtures found in the attached nebules, micro or even nano administration through the respiratory tract, within the human body and/or effective sound. the use of light sources or the so-called ULV or similar environmental cleaning and disinfection in micro or even nano particles size with devices the life cycles of harmful microorganisms as a result of using breaking/destroying externally and internally with these methods used includes methods.
Insanlar, hayvanlar, bitkiler ve diger canlilar için 2017/13260 numarali patentimiz kapsamindaki ana yol ve yöntemlerden de döngü modelimiz çerçevesinde ayrica faydalanilacaktir. Our patent number 2017/13260 for humans, animals, plants and other living things Within the framework of our loop model, one of the main ways and methods within the scope of will be used.
Bahis olunan problemlerin çözüm döngü modeli ve bu kapsamda gelistirilen somut ve soyut etki saglayan diger bütün önlemler iki ana baslik altinda ele alinmistir. The solution loop model of the mentioned problems and the concrete model developed in this context and all other measures that have an intangible effect are discussed under two main headings.
Somut önlemler, Biyolojik tehditleri önleme ve yok etme seklinde iki asamalidir. l. Somut önlemler: Biyolojik tehdit canli sagligini etkilemeden önce (aksatmadan ve her bir ortam için belirlenecek periyodlarda planlanarak uygulanmalidir), a. Önleyici temizlik ve tedbirler (Her an tehdit varmis gibi), b. Klasik Sanitasyon ve Hijyen (Tehdit ve yapisi bilinmiyorsa). Concrete countermeasures are two-stage: prevention and elimination of biological threats. l. Concrete measures: Before the biological threat affects the health of living things (without disruption and with each should be planned and implemented in periods to be determined for the environment), a. Preventive cleaning and measures (as if there is a threat at any moment), b. Classical Sanitation and Hygiene (if the threat and its nature are unknown).
Biyolojik tehdit insan sagligini olumsuz etkilediginde (epidemi hatta pandemi olasiliklari çok yüksekse), a. Bireysel ve toplumsal acil tedbir ve/veya karantina uygulanmalidir. b. Hastalanmis insanlar için aninda etki edecek sivi gida gibi veya solunum yolundan uygulanacak özel sivi karisimlar verilir(1. Mayi), c. Bagisiklik sistemi güçlendirilecek özel sivi karisimlar verilir(2. Mayi), Biyolojik tehdit canli sagligini etkiledikten sonra, 3. Epidemiyoloji bilim ve teknikleri yardimiyla elde edilen enzimler veya Bakteriyofaji engellemek için faydali Etkin Mikroorganizmalardan(EM) elde edilen yabanci DNA'yi yikimlayan enzimler kullanarak yani restriksiyon endonükleazlari (Tehdit ve yapisi her ikisi de biliniyorsa) veya Virüfaj ile dâhili hastalik için müdahale edilir(3. Mayi). Bunun sonucu olarak bakteriler av virüs avciyken islem bu uygulamayla tersine dönerek Virüs av bakteri avci b. Hastalanmis insanlara Bioakustik biliminden faydalanmak basta olmak üzere, Mikroorganizmalarin hareket analizi, frekans tespiti yapilarak gerek görüldügünde ses ve/veya isik ve/veya manyetik alan ile bunlarin yapisini direkt bozucu bir tepki tedavisi uygulanir. c. Hasta iyilesince taburcu olduktan sonra en az 15 gün takip edilir ve bütün bilgiler bir veri tabaninda toplanir. d. Havadan, Karadan veya Sudan yayilmalarda (a) bendinde açiklanan metot ile enzim olusturan EM ordulari ile salgina haricen ortam hijyeni için müdahale edilir. Kisacasi saldirganlara ortam dar edilir. e. Bir binadaki her bir dairenin yasam ve çalisma alanlarina girislerde ve/veya içerisine konulacak dört bölümlü üstten tek kapakli bir hijyen kutusu ideal ölçüleri y=50, e=35, u=70 cm olup, bu kutunun ana bilesenleri ve islevleri ayrintili olarak Sekil - 1 ile açiklanmistir. When the biological threat adversely affects human health (such as epidemic or even if pandemic probabilities are very high), a. Individual and social emergency measures and/or quarantine should be applied. b. Like liquid food that will act instantly for people who are sick or Special liquid mixtures to be administered through the respiratory tract are given (1. May), c. Special liquid mixtures are given to strengthen the immune system (2. May), After the biological threat affects the health of animals, 3. Enzymes obtained with the aid of epidemiological science and techniques, or Effective useful for inhibiting bacteriophage Destroys foreign DNA obtained from microorganisms (EM) using enzymes, namely restriction endonucleases (Threat and (if the nature is both known) or for internal disease with Virufage intervene (3rd May). As a result, bacteria prey virus When you are a hunter, the process is reversed with this application. Virus hunting bacteria hunter b. Benefiting from the science of Bioacoustics to sick people is the first priority. movement analysis of microorganisms, frequency detection sound and/or light and/or magnetic With the area, a reaction treatment that directly disrupts their structure is applied. c. When the patient recovers, they are followed up for at least 15 days after discharge, and All information is collected in a database. D. In case of air, land or water dispersion, as explained in subparagraph (a), The environment outside the epidemic with the EM armies that create enzymes with the method intervened for hygiene. In short, the environment is narrow for the attackers. to. Entrances to the living and working areas of each flat in a building and/or a hygiene system with four sections and a single lid from the top to be placed inside. The ideal dimensions of the box are y=50, e=35, u=70 cm. Its components and functions are explained in Figure - 1 in detail.
Ana Islem ve Bölme Numaralari (1)- Hijyen Kutusu (Mukavemet ve isi yalitim kaplamali) (2) - UV isik (3)- Hijyen sivisi deposu ve nano/mikro parça püskürtme sistemi (4) - Giyecek ve diger malzemeler konacak bölme (5) - Ayakkabi vb. konacak bölme (6) - Askili raf (Para, anahtarlar vb. için) (7) - Sadece ambalajli yiyecek, içecek konacak bölme(UV yok). Main Process and Partition Numbers (1)- Hygiene Box (Strength and heat insulation coated) (2) - UV light (3)- Hygiene liquid tank and nano/micro part spray system (4) - Compartment for clothes and other materials (5) - Shoes etc. compartment (6) - Hanging shelf (For money, keys, etc.) (7) - Only packaged food and beverage compartment (no UV).
Hijyen Islemi Içerisinde virüs ve bakterileri yok eden hijyen kutusu(1) ve içeriginde hijyen (4. Mayi) 13 sn. püskürtülerek(3), giyecekler (4), ayakkabilar(5), paralar, anahtarlar askili raf(6) seklinde ayri bölmelerde ancak birlikte tek bir kutu içerisinde dezenfekte edilirler. Hygiene Process Hygiene box (1) that destroys viruses and bacteria in it and its contents hygiene (4th May) 13 sec. by spraying (3), clothing (4), shoes(5), coins, keys separately as hanging rack(6) they are disinfected in the compartments only together in a single box.
Yiyecek ve içecekler UV isik olmayan bölümde(7) arindirildiktan sonra içeri alinirlar. Hijyen kutusu(1) kapagi kapandiktan UV lsik(2) ve 4. Mayi(3) ortalama 13 sn. uygulandiktan sonra kapak açilir. After the food and beverages are purified in the UV-free section(7) Then they are taken in. After closing the hygiene box(1), UV light(2) and 4. May(3) average 13 sec. After application, the cover is opened.
Bütün binalarin ana su girislerine mutlaka kimyasal ve biyolojik (UV Bütün bina ve dairelerdeki yasam alanlarina özellikle akilli sehirler dahil mutlaka 2011/02364 patentteki yardimci üniteler konulur. Bina ve dairelerin bütün yasam alanlarina konan yardimci üniteler ve otomatik dezenfektasyon sistemleriyle 4. Mayi uygulanir. Esya tasinma islemlerinde esyalar için ayri bir giris-çikis ve/veya asansör ve/veya mekanik sistem mimari projelere dâhildir. Bu alanlar kullanima baslandigi andan itibaren özellikle 4. Mayi ile nano partiküller püskürtülmek suretiyle dezenfekte edilmelidir. Kisacasi yapilmasi planlanan akilli sehirlerde Kimyasal, Biyolojik, Radyolojik, Nükleer (KBRN) tehditlere karsi benzer sekilde tedbir alinmalidir. Chemical and biological (UV) must be applied to the main water inlets of all buildings. Smart cities especially for living spaces in all buildings and apartments Auxiliary units in the 2011/02364 patent are included. Building and auxiliary units placed in all living areas of apartments and 4. May is applied with automatic disinfection systems. Goods A separate entrance-exit and/or elevator for the goods in the moving process and/or mechanical system are included in architectural projects. These areas From the moment it started to be used, especially with the 4th May, nano particles should be disinfected by spraying. In short Chemical, Biological, Radiological, Similar precautions should be taken against nuclear (CBRN) threats.
Soyut önlemler: Biyolojik tehdit canli sagligini etkilemeden öncei a. Her duruma karsi önceden tedbir olarak bireysel, aile içi ve toplumsal egitim ve ögretim çalismalari Kimyasal, Radyolojik hatta Nükleer tehditlerde dâhil edilerek yapilir (Her an tehdit varmis gibi), b. Saglam bir bireysel ruh yapisina sahip olmak için ruhsal sifa metotlarindan basta transandantal meditasyon teknikleri ve Esma-ül Hüsna olmak üzere çesitli bireysel veya toplumsal zikir faaliyetleri mutlaka uygulanmalidir. 2. Biyolojik tehdit insan sagligini olumsuz etkilediginde, a. Aninda tecrit ve/veya karantina uygulandiginda, insanlarin Ruhsal bagisiklik sistemleri çesitli metotlarla güçlü tutulur, b. Tecrit veya karantinaya alindigi andan taburcu olana kadar geçecek süre için bütün maddi kaygilarini giderecek her türlü tedbir alinir. 0. Hasta iyilesecegi konusunda olumlu motive edilir. d. Her durumda 1. Madde (a) ve (b) bendi uygulamalara devam edilir. 1. Biyolojik tehdit canli sagligini etkiledikten sonra, 8. Dünya çapinda bir etki oldugunda iyilesen bireyler eski yasantilarinin olmayacagina ve artik yeni bir yasam biçimi baslayacaginin bilinciyle olumlu motive edilirler. b. Her durumda 1. madde (a) ve (b) bendi uygulamalara devam edilir. Abstract measures: Before biological threat affects living health a. As a precaution against any situation, individual, family and social education and training studies Chemical, Radiological and even Nuclear It is done by including threats (as if there is a threat at any moment), b. Spiritual healing to have a sound individual soul structure Transcendental meditation techniques and Esma-ül Various individual or social dhikr activities, especially husna must be implemented. 2. When the biological threat adversely affects human health, a. When immediate isolation and/or quarantine is applied, people's Spiritual immune systems are kept strong by various methods, b. It will pass from the moment of isolation or quarantine until discharge All kinds of measures are taken to eliminate all financial concerns for the duration. 0. The patient is positively motivated that he will recover. D. In any case, the applications of Article 1 (a) and (b) are continued. 1. After the biological threat affects the health of animals, 8. Individuals who recover when there is a worldwide impact With the awareness that it will not happen and that a new way of life will begin now, are positively motivated. b. In any case, the applications of item 1 (a) and (b) are continued.
Bahis olunan sivi gida gibi veya solunum yolundan uygulanacak özel sivi karisimlardan 1. Mayi'de bulunan Kolloidal gümüs suyu, buhar damitimli su içinde (deiyonize su) özel bir yöntemle %99,9 saflikta gümüs metali kullanilarak, kolloidal yapiya getirilmesi ile elde edilen sudur. The mentioned liquid such as food or special liquid to be administered through the respiratory tract Colloidal silver water found on 1st May, in steam distilled water (deionized water) using 99.9% pure silver metal with a special method, colloidal It is the water obtained by bringing it to the structure.
Organik ve inorganiklerden tamamen arindirilmis suya deiyonize su, demineralize su, distile su veya saf su denir. Genel olarak endüstriyel süreçlerde ve Saf suyun içerisinde bulunan kolloid miktari, gümüs suyunun içerdigi gümüs kolloid oranini belirler. Gümüs suyunun veya altin suyunun içerisindeki gümüs veya altin kolloid miktari Parts Per Million (Ppm) olarak ölçülür. Deionized water, demineralized to water completely free of organic and inorganic water is called distilled water or pure water. In general industrial processes and The amount of colloid in pure water is the amount of silver contained in silver water. determines the colloid ratio. Silver in silver water or gold water or the amount of gold colloid is measured in Parts Per Million (Ppm).
Amerika Birlesik Devletleri Çevre Koruma Ajansi tarafindan 1991 yilinda yayinlanan ve bir ömür boyu zararli etkilere maruz kalma olasiligi düsük olan tahmini günlük gümüs maruziyeti temsil eden referans dozu 5 ug/(kg-d) (pg = mikrogram) seklindedir. Fazla kullanimi argyria (mavi cilt sendromu) ile hafif bas dönmesi ve bulantiya neden olabilir. Maksimum kullanim 14 gündür. Kolloidal gümüs, modern reçeteli antibiyotik karsitliginin aksine, öldürülen organizmalarda direnç veya bagisiklik olusturmaz. in 1991 by the United States Environmental Protection Agency. published and is unlikely to be exposed to harmful effects in a lifetime The reference dose representing the estimated daily silver exposure is 5 ug/(kg-d) (pg = micrograms). Mild headache with overuse argyria (blue skin syndrome) may cause dizziness and nausea. Maximum usage is 14 days. colloidal silver, unlike its modern prescription antibiotic counterpart, is resistant to killing organisms. does not produce resistance or immunity.
Gümüs parçaciklarinin saf su içerisinde homojen olarak dagilmis haline gümüs suyu denir ve 6 dakikada etkisini gösterir. Agiz yolu ile uygun miktarda rahatlikla kullanilabilir. Gümüs partiküllerinin ayni elektrik yüküne sahip olup birbirini itmesi ve homojen olarak dagilmasi, vücutta yigilma yapmamasina olanak saglar. Belli bir süre dolasim sisteminde görevlerini tamamladiktan sonra sindirim sistemi yoluyla disari atilirlar. Hem homojen olup birbirine temas etmemesi, hem de sindirim sistemi yoluyla kolaylikla atilabilmesi özelliklerinden dolayi, koloidal gümüs suyu hiçbir yan etkiye ve kalici etkiye sahip degildir. Silver particles are homogeneously dispersed in pure water. It is called water and shows its effect in 6 minutes. Conveniently, in an appropriate amount through the mouth can be used. Silver particles have the same electrical charge and repel each other and homogeneously dispersed, it allows not to accumulate in the body. Clear after completing its tasks in the circulatory system for a while, the digestive system they are expelled through. It is both homogeneous and not in contact with each other, and Due to its easy excretion through the digestive system, colloidal silver water has no side effects and no permanent effects.
Bu sekilde olusturulan etken ve etkili modelde bahis olunan Biyolojik tehdit ve saldirilara karsi solunum veya besin yani oral yoldan uygulanacak organik sivi ürünlerin içerigi ise sunlardir. (Hastaligin seviyesine göre dozaj ayarlanmalidir.) l. Birinci Mayi içerigi (1000 ml) lsik almayan cam sisede muhafazali 1. Süzülme metodu ile ceviz/ceviz yagindan veya ceviz yapragindan veya en az % 99,9 saflikta gümüsün elektrolizi ile elde edilen mono nano parçaciklar boyutu 1-5 nm (nano metre) arasinda en az 40 ppm oranda degisen gümüs iyonlarina sahip dâhili ve/veya harici kullanilabilen Kolloidal Gümüs Suyu 140 ml, 2. Bitkisel organik Gliserol en az % 99,7 saflikta 40 ml, 3. Bitkisel organik D-Limonen 3 ml 4. Sodyum bikarbonat (NaHCOS) 40 ml . Saf su 777 ml. (veya 776 ml + 1 ml Zemzem suyu daha etkili olur) ll. Ikinci Mayi içerigi (1000 ml) Isik almayan cam sisede muhafazali 1. Benzer tekniklerle ve miktar-oranlarda elde edilen en az 30 ppm oranda degisen altin iyonlarina sahip Kolloidal Altin suyu 140 ml. 2. Bitkisel organik Gliserol en az % 99,7 saflikta 40 ml, 3. Bitkisel organik D-Limonen 3 ml, 4. Sodyum bikarbonat (NaHCOS) 40 ml . Saf su 777 ml. (veya 776 ml + 1 ml Zemzem suyu daha etkili olur) Hasta Tedavisi Için Kullanim: (Detaylar için TABLO - 1”e bakiniz) Hastaya, 1. Mayi ilk kullanimdan önce mavi sisesini ivice calkalavarak 250 ml miktarda oral yoldan içirilir. Takip eden diger 6. saatte yine mayi sisesini iyice uygulanir ve her oral/solunum kullanimindan 30 dk. sonra 1,3 ml sigla balzami ilaveli 500 ml içme suyu içirilir, içemiyorsa damardan hastaya 500 ml sivi takviyesi yapilir. (Alerji hikayesi olana Sigla yagi-balzami verilmez) 2. Mayi; 1. Mayi'nin kullanimi bittikten sonraki 6. Saatte, yani uygulama basladiktan 18 saat sonra ilk defa ve kullanmadan önce mayi sisesini iyice çalkalayarak oral yoldan 250 ml olarak hastaya verilir. Takip eden diger 6. saatte yine mavi sisesini iyice calkalavarak 250 ml nebül'e doldurup solunum yolundan verilir ve her oral/solunum kullanimindan 30 dk. sonra 1.3 ml sigla balzami ilaveli 500 ml içme suyu içirilir, içemiyorsa damardan 500 ml sivi takviyesi yapilir. Biological threat and risk mentioned in the effective and effective model created in this way. organic liquid to be administered orally against attacks by respiration or food. The contents of the products are as follows. (Dosage should be adjusted according to the level of the disease.) l. First May content (1000 ml) Preserved in an irradiated glass bottle 1. It is made of walnut/walnut oil or walnut leaf or most Mono nanoparticles obtained by electrolysis of silver with a purity of less than 99.9% silver ranging in size from 1-5 nm (nano meter) at a rate of at least 40 ppm Colloidal Silver Water that can be used internally and/or externally with ions 140 ml, 2. Vegetable organic Glycerol with a purity of at least 99.7%, 40 ml, 3. Herbal organic D-Limonene 3 ml 4. Sodium bicarbonate (NaHCOS) 40 ml . Pure water 777 ml. (or 776 ml + 1 ml Zamzam water would be more effective) ll. Second May content (1000 ml) Stored in an opaque glass bottle 1. At a rate of at least 30 ppm obtained with similar techniques and amount-to-ratio Colloidal Gold water with varying gold ions 140 ml. 2. Vegetable organic Glycerol with a purity of at least 99.7%, 40 ml, 3. Herbal organic D-Limonene 3 ml, 4. Sodium bicarbonate (NaHCOS) 40 ml . Pure water 777 ml. (or 776 ml + 1 ml Zamzam water would be more effective) Use for Patient Treatment: (See TABLE - 1 for details) Before using the 1st May for the first time, the patient shakes the blue bottle with the ivice and gives 250 ml. amount is taken orally. In the next 6 hours, again, thoroughly clean the fluid bottle. It is applied and 30 minutes after each oral/respiratory use. then 1.3 ml of sigla balsam Additional 500 ml of drinking water is given to the patient, if he cannot drink, 500 ml of liquid supplementation is given to the patient intravenously. makes. (Sigla oil-balsam is not given to those with a history of allergy) 2. May; 1. At the 6th hour after the use of May, that is, the application For the first time 18 hours after starting and before use, thoroughly rinse the fluid bottle. It is given to the patient as 250 ml orally by shaking. In the next 6 hours again, shaking the blue bottle thoroughly, filling it into 250 ml nebules and leaving it from the respiratory tract. It is given and 30 minutes after each oral/respiratory use. then add 1.3 ml of sigla balsam 500 ml of drinking water is drunk, if not, 500 ml of fluid is supplemented intravenously.
Dolayisiyla iki mayi grubu arasinda en az 6 saatlik bir ara saglanmis olur. Her gün mutlaka durum kontrolü yapilir. Sonuç olumlu olsa dahi tedbir amaçli bir periyod yani 2 gün daha bu sekilde uygulamaya devam edilir. Sonuç olumsuz ise maksimum uygulama 14 gün yani 7 periyod olduguna dikkat edilerek uygulanir. Therefore, a break of at least 6 hours is provided between the two fluid groups. Everyday A status check must be made. Even if the result is positive, a precautionary period that is, the application is continued in this way for 2 more days. If the result is negative It is applied by paying attention to the fact that the maximum application is 14 days, that is, 7 periods.
Hastanin iyilestigine tespit edildiginde uygulama sonlandirilir. Örnegin; sabah suyunu yine cam bardak ile oral yoldan alir ve öglen 12.00'de yine 250 ml 1. When it is determined that the patient has recovered, the application is terminated. For example; morning He takes his water orally with a glass glass again and at 12:00 noon, 250 ml 1.
Mayi'yi Nebülizatör ile bu sefer solunum yolundan alir. ml içme suyunu yine cam bardak ile oral yoldan alir ve gece 2400'de yine 250 ml 2. Mayi'yi Nebülizatör ile bu sefer solunum yolundan alir. He takes May from the respiratory tract with a Nebulizer this time. He takes orally with a glass cup of drinking water and 250 ml again at 2400 at night. 2. He takes the fluid from the respiratory tract with a Nebulizer this time.
Dolayisiyla 1. gün tamamlanir ve 2. günde ayni metot devem ettirilerek maksimum 14 gün ve 7 periyoddan ibaret olan periyodlardan birincisi tamamlanmis olur (TABLO-1). Bu arada ilk günden itibaren tedavi bitene kadar veya olumsuz bir durum ortaya çikana kadar sadece 1. Mayi her bir göze 6 saatte 1 damla olacak sekilde aksatilmadan damlatilmalidir. Therefore, the 1st day is completed and the same method is continued on the 2nd day and the maximum The first of the periods, consisting of 14 days and 7 periods, is completed. (TABLE-1). In the meantime, from the first day until the end of the treatment or a negative Until the situation arises, only the 1st May will be 1 drop in each eye every 6 hours. It should be dripped without interruption.
Burada dikkat edilecek diger hususlar: . Oral veya solunum uygulamalarindan 20 dakika önce ve 20 dakika sonra hiçbir sey yenmemeli ve içilmemelidir! 0 Damar yolundan veya deri altina uygulanmaz! o Mayi sisesinin agzi kullanim harici mutlaka iyice kapali tutulmalidir. Other things to note here: . 20 minutes before and 20 minutes after oral or inhalation administration Nothing should be eaten or drunk! 0 Not administered intravenously or subcutaneously! o The mouth of the May bottle must be kept tightly closed except for use.
Günde 4 defa, 6 saatte 1 damla olacak sekilde içerisinde sadece Kolloidal Gümüs Suyu olan 1. Mayiden hastanin her bir gözüne 1'er damla olacak sekilde mutlaka damlatilmalidir. Diger 2. Mayi göze kullanilmaz. Yanlislikla kullanilirsa da göze bir zarari olmaz. 1. Mayi 'de bulunan kolloidal gümüsün avantajlari, 2. Mayi 'de bulunan kolloidal altin suyu içinde geçerli olup, ilave olarak altin suyu bagisiklik sistemini güçlendirir ve her iki Mayi 'de dâhili ve harici güvenle kullanilabilir. 1. ve 2. Mayi içerigi hiçbir metal ile temas ettirilmemelidir. Only Colloidal in 4 times a day, 1 drop in 6 hours. From the 1st May, which is Silver Water, there will be 1 drop in each eye of the patient. It must be dripped in the form of drops. The other 2. May not be used on the eyes. By mistake Even if used, it will not harm the eyes. Advantages of colloidal silver found on May 1st valid in colloidal gold water, additionally gold water is immune strengthens the system and can be used in both May internally and externally with confidence. The 1st and 2nd liquid contents should not come into contact with any metal.
Ucu metal enjektörle mayi sivisi siseden çekilmemelidir. Fluid should not be drawn from the bottle with a metal injector.
Gözlerde uygulama için cam yoksa plastik pipet kullanilabilir. If there is no glass for application in the eyes, a plastic pipette can be used.
Oda sicakliginda ve isik görmeyen yerde muhafaza edilmeli ve buzdolabina konmamalidir. It should be stored at room temperature and out of light and kept in the refrigerator. should not be placed.
Elektronik cihazlardan uzak tutulmalidir. It should be kept away from electronic devices.
Gümüs veya altin suyu kullanildiginda çig sarimsak ve alkol tüketilmemesi gereklidir. Not consuming raw garlic and alcohol when using silver or gold water is necessary.
Dâhili oral kullanimlarda mutlaka cam veya porselen fincan kullanilmali, Metal kasik ve uygulamaya basladiktan sonra dis teli kullanilmamalidir. For internal oral use, glass or porcelain cups should be used, Metal groin and braces should not be used after starting the application.
Hamilelerin gerekmedikçe kullanmasi tavsiye edilmez. It is not recommended for pregnant women to use it unless necessary.
Alerjik bünyelerde 500 ml içme suyu takviyesinin içerisine sigla konulmaz Laboratuvarlarda suni olarak üretilen ve özellikle solunum yollarinda etkili virüsler için bir anestezi uzmani esliginde nebülatör uygulamasi öncesi hastayi bayiltmayacak kadar çok az bir oranda eter koklatilmalidir. No sigla is put into 500 ml drinking water supplement for allergic bodies. It is produced artificially in laboratories and is especially effective in the respiratory tract. before nebulator application for viruses in the presence of an anesthesiologist A very small amount of ether should be sniffed so as not to make the patient faint.
Bu süreç esnasinda hastanin Ates, Nabiz ve Tansiyon (ANT) periyodik olarak alinir ve ANT' de bir olumsuzluk görüldügünde tedavi kesilmeden ANT ile ilgili gerekirse ilave tibbi tedbirler alinmak suretiyle söz konusu özel 1. ve 2. Mayi'nin kullanimina ara verilmeden tedaviye devam edilir. During this process, the patient's Temperature, Pulse and Blood Pressure (ANT) is periodically monitored. It is taken and when a negativity is observed in ANT, without discontinuing the treatment, If necessary, by taking additional medical measures, the aforementioned special 1st and 2nd May The treatment is continued without interrupting its use.
HASTA TEDAVI VAKIT DOZAJ TABLOSU Sira Periyod Gun Vakit Zaman Aralik Uygulama 1.Mayi 2.Mayi Toplam No. Sayisi Saat Saat ml ml ml 3. Mayi: Içeriginde Enzim veya virüfaj vardir. Bu enzimler bilinmeyen bir veya birkaç virüs tehlikesi basladiginda yapilan ARGE çalismalari sonucu iki tipi vardir: Epidemiyoloji bilim ve teknikleri yardimiyla elde edilen enzimler veya Bakteriyofaji engellemek için faydali Etkin Mikroorganizmalardan(EM) elde edilen yabanci DNA'yi yikimlayan enzimler kullanarak yani restriksiyon endonükleazlari - RE (Tehdit ve tehdidin yapisi her ikisi de biliniyorsa) veya Virüfaj (VJ) ile dahili hastalik için gelistirilen tehdide karsi olusturulan bir virüs ordusu kullanilmasidir. PATIENT TREATMENT TIME DOSAGE TABLE Sequence Period Day Time Time Interval Application 1st May 2nd May Total no. Number of Hours Hours ml ml ml 3. May: Contains Enzyme or Virufage. These enzymes are unknown or There are two types as a result of the R&D studies done when a few virus threats started: Enzymes or Bacteriophage obtained with the help of epidemiological science and techniques foreign substances obtained from Active Microorganisms (EM) useful for preventing Restriction endonucleases using enzymes that degrade DNA - RE Internal disease (if threat and nature of threat are both known) or Viral (VJ) It is the use of an army of viruses created against the threat developed for
Kisacasi 3. Mayi - RE ve VJ olmak üzere iki farkli formdadir. Her iki form ayni anda uygulanmaz. RE için çalisma sirasinda son konsantrasyonda star aktiviteye neden olmamak için 3. Mayi - RE içeriginde % 5'ten fazla gliserol asla bulunmamaktadir. Damar yolu veya oral veya serum içi iv yapilarak kullanilir. Çevre, kisisel ve toplumsal hijyen açisindan: 4. Mayi: Haricen kullanildigi için hijyen sivisi (HS) olarak adlandirilmaktadir. Iki türdür. Birincisi özellikle gida ve su kaynaklarina karsi tehdit ve tehlikeye karsi restriksiyon endonükleazlari - RE ile güçlendirilmis etkin mikroorganizmalar (HS - EM) veya virüfaj (HS-VJ) kisaca sadece 3. Mayi içeriginin saf su ile karisimi veya normal su ile seyreltilmis (antiseptik eriyik) içerisinde seyreltilmis .level/Çamasir suyu ve süblime asit fenik ile sigla yagi, aleo-vera, Bitkisel organik D-Limonen içeren dezenfektasyon sivisi (HS-OL) olmak üzere iki farkli tiptedir. Her ikisi ayni anda uygulanmaz. Birincisi yasam alanlarinda, ikincisi dis ortamda püskürtülerek kullanilir. In short, 3. May - It is in two different forms as RE and VJ. both forms are the same not applicable at this time. For RE, star activity at the final concentration during the study 3. May - Never more than 5% glycerol in RE content does not exist. It is used by intravenous or oral or intravenous IV administration. In terms of environment, personal and social hygiene: 4. May: It is called as hygiene liquid (HS) because it is used externally. Two is species. The first one is against the threat and danger especially against food and water resources. restriction endonucleases - RE-enhanced active microorganisms (HS - EM) or virufage (HS-VJ) for short, only 3. Mixture of fluid content with distilled water or .level/Laundry diluted in normal water (antiseptic solution) juice and sublimated acid phenic with sigla oil, aloe-vera, Herbal organic D-Limonene It is of two different types, containing disinfection liquid (HS-OL). both the same not applicable at this time. The first is by spraying in living areas, the second by spraying outdoors. used.
Sekil 1'de açiklanan (3)- Hijyen sivisi deposu ve nano/mikro boyut ayarli parçacik püskürtme sisteminin fonksiyon olarak aynisi burada da kullanilmaktadir. Described in Figure 1 (3)- Hygiene liquid tank and nano/micro size adjustable The same function of the particle spray system is used here as well.
Ancak buradaki bir farki püskürtme sisteminin bagimsiz ve gerektiginde mobil olarak kullanilmasidir. However, the difference here is that the spray system is independent and mobile when necessary. is to be used as.
Claims (1)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2020/05416A TR202005416A2 (en) | 2020-04-06 | 2020-04-06 | EFFECTIVE SOLUTIONS AGAINST BIOLOGICAL THREATS AND HAZARDS |
PCT/TR2021/050230 WO2021206653A2 (en) | 2020-04-06 | 2021-03-16 | Effective solutions against biological threats and hazards |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2020/05416A TR202005416A2 (en) | 2020-04-06 | 2020-04-06 | EFFECTIVE SOLUTIONS AGAINST BIOLOGICAL THREATS AND HAZARDS |
Publications (1)
Publication Number | Publication Date |
---|---|
TR202005416A2 true TR202005416A2 (en) | 2020-07-21 |
Family
ID=75470105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2020/05416A TR202005416A2 (en) | 2020-04-06 | 2020-04-06 | EFFECTIVE SOLUTIONS AGAINST BIOLOGICAL THREATS AND HAZARDS |
Country Status (2)
Country | Link |
---|---|
TR (1) | TR202005416A2 (en) |
WO (1) | WO2021206653A2 (en) |
-
2020
- 2020-04-06 TR TR2020/05416A patent/TR202005416A2/en unknown
-
2021
- 2021-03-16 WO PCT/TR2021/050230 patent/WO2021206653A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2021206653A9 (en) | 2021-12-02 |
WO2021206653A2 (en) | 2021-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yan et al. | New clinical applications of electrolyzed water: a review | |
Yu et al. | Biosafety materials: an emerging new research direction of materials science from the COVID-19 outbreak | |
US20080310996A1 (en) | Germicidal Floor System (GFS) | |
Khan et al. | Efficacy of green cerium oxide nanoparticles for potential therapeutic applications: Circumstantial insight on mechanistic aspects | |
CN102754668A (en) | Novel Chinese herbal medicine compound disinfectant solution | |
US20150306151A1 (en) | Polarized scorpion venom solution and a method for making polarized scorpion venom solution | |
TR202005416A2 (en) | EFFECTIVE SOLUTIONS AGAINST BIOLOGICAL THREATS AND HAZARDS | |
Ali et al. | Assessment of the effect of Allium sativum on serum nitric oxide level and hepatic histopathology in experimental cystic echinococcosis in mice | |
Bakour et al. | New insights into potential beneficial effects of bioactive compounds of bee products in boosting immunity to fight COVID-19 pandemic: Focus on zinc and polyphenols | |
Kenko Nkontcheu et al. | Five year (2013-2017) trends in poisoning among patients of the Buea Regional Hospital, South-West Region (Cameroon) | |
Sawan et al. | Antimicrobial/anti-infective materials: principles and applications | |
Thomas | Sensitivity and resistance of protozoa to microbicides | |
CN104095789A (en) | Special Chinese honey locust liquid soap used in clinical laboratory and preparation method thereof | |
Jari et al. | Therapeutic effects of silver nanoparticles loaded with albendazole, mebendazole drugs in male albino mice infected with hydatid cysts | |
Raloff | The antibiotic vitamin | |
Rai et al. | Cuprous oxide-or copper-coated jute stick pieces at an air–water interface for prevention of aerial contamination in potable water | |
US20120156154A1 (en) | Preservative and Embalming Method and System | |
Purdom | Environment and Health | |
Wright | The Big Book of Infectious Disease Trivia: Everything You Ever Wanted to Know about the World's Worst Pandemics, Epidemics, and Diseases | |
Crocetto et al. | Novel Key Ingredients in Urinary Tract Health—The Role of D-mannose, Chondroitin Sulphate, Hyaluronic Acid, and N-acetylcysteine in Urinary Tract Infections (Uroial PLUS®) | |
Fites Jr | Evasion of adaptive immune defenses by the lethal chytrid fungus Batrachochytrium dendrobatidis | |
Pant et al. | A pandemic of infectious diseases due to new etiological agents predisposing factors, case study of COVID-19 and control measures | |
Zhang et al. | Novel Antibacterial Metals as Food Contact Materials: A Review | |
Toledano et al. | Antioxidant and Immune-Related Implications of Minerals in COVID-19: A Possibility for Disease Prevention and Management | |
Llewellyn | Marine biotoxins in history: misuse and mayhem |